Peptilogics
Peptilogics is a biotechnology company developing novel peptide therapeutics using machine learning and automation. The company integrates hardware, software, chemistry, and molecular biology to support drug development and research. The Senior Director, Corporate Operations, will oversee strategic and operational initiatives to drive growth and efficiency.
Peptilogics is a biotechnology company focused on peptide therapeutics, using custom engineering to design and develop next‑generation peptide drugs. They provide tailored peptide design, synthesis and optimization services to support drug discovery and preclinical development for research groups and industry partners. Branded “Custom Engineered with Intention,” Peptilogics positions itself to accelerate translation of peptide technologies into therapeutic candidates and collaborations.
Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial
Oct 16, 2025
Peptilogics raises millions to fund pivotal trial for prosthetic joint infection treatment
Oct 16, 2025
South Side biotech company raises $78 million for new drug to kill prosthetic joint infections
Oct 16, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Peptilogics.
Peptilogics: $78 Million Raised For Advancing Zaloganan Toward Pivotal Trial For Prosthetic Joint Infections
Oct 16, 2025
Senior/Principal Scientist, Medicinal Chemistry – Peptide Drug Design
SPH Media
Scientist I or II - Peptide Chemistry
City of Winnipeg
Eikon Clinical Talent Community
Eikon Therapeutics
Senior Principal Scientist, Peptide Therapeutics
1000 Genentech, Inc.
Eikon G&A Talent Community
Eikon Therapeutics
Director, Clinical Operations
Absci